Non-invasive pneumococcal pneumonia in Portugal - Serotype distribution and antimicrobial resistance

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Horácio, Andreia N ^a   Lopes, Joana P ^a   Ramirez, Mário ^a   Melo Cristino, José ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; ETHYLHYDROCUPREINE; LEVOFLOXACIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; MIKAMYCIN B; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NON INVASIVE PNEUMOCOCCAL PNEUMONIA; NONHUMAN; PORTUGAL; PREVALENCE; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; AGED; CLASSIFICATION; DRUG EFFECTS; HEALTH SURVEY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; SEROTYPING; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; POPULATION SURVEILLANCE; PORTUGAL; SEROGROUP; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84905040478     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103092     Document Type: Article

References (31)

1. Polverino E, Torres A, Menendez R, Cillóniz C, Valles JM, et al. (2013) Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study. Thorax 68: 1007-1014. doi:10.1136/thoraxjnl-2013-203828.
2. Said MA, Johnson HL, Nonyane BAS, Deloria-Knoll M, O'Brien KL, et al. (2013) Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PloS One 8: e60273. doi:10.1371/journal.pone.0060273.
3. Rodrigo C, Bewick T, Sheppard C, Greenwood S, Macgregor V, et al. (2014) Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status. Thorax 69: 168-173. doi:10.1136/thoraxjnl-2013-203987.
4. Cillóniz C, Torres A (2012) Understanding mortality in bacteremic pneumococcal pneumonia. J Bras Pneumol 38: 419-421.
5. Benfield T, Skovgaard M, Schønheyder HC, Knudsen JD, Bangsborg J, et al. (2013) Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines. PloS One 8: e72743. doi:10.1371/journal.pone.0072743.
6. Smith KJ, Wateska AR, Nowalk MP, Raymund M, Nuorti JP, et al. (2012) Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine. JAMA J Am Med Assoc 307: 804-812. doi:10.1001/jama.2012.169.
7. Sherwin RL, Gray S, Alexander R, McGovern PC, Graepel J, et al. (2013) Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. J Infect Dis 208: 1813-1820. doi:10.1093/infdis/jit506.
8. Sá-Leão R, Pinto F, Aguiar S, Nunes S, Carriço JA, et al. (2011) Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol 49: 1369-1375. doi:10.1128/JCM.01763-10.
9. Heron M (2013) Deaths: leading causes for 2010. Natl Vital Stat Rep 62: 1-97.
10. Grabenstein JD (2012) Effectiveness and serotype coverage: key criteria for pneumococcal vaccines for adults. Clin Infect Dis 55: 255-258. doi:10.1093/cid/cis354.
11. Trück J, Lazarus R, Jonsdottir I, Klugman KP, Pollard AJ (2012) Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine program in older adults at present. Clin Infect Dis 55: 1577-1579. doi:10.1093/cid/cis700.
12. Fedson DS, Nicolas-Spony L, Klemets P, van der Linden M, Marques A, et al. (2011) Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert Rev Vaccines 10: 1143-1167. doi:10.1586/erv.11.99.
13. Horácio AN, Diamantino-Miranda J, Aguiar SI, Ramirez M, Melo-Cristino J, et al. (2012) Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections. Vaccine 30: 218-224. doi:10.1016/j.vaccine.2011.11.022.
14. Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M (2008) Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin Microbiol Infect 14: 835-843. doi:10.1111/j.1469-0691.2008.02031.x.
15. Aguiar SI, Brito MJ, Gonçalo-Marques J, Melo-Cristino J, Ramirez M (2010) Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 28: 5167-5173. doi:10.1016/j.vaccine.2010.06.008.
16. Regev-Yochay G, Rahav G, Riesenberg K, Wiener-Well Y, Strahilevitz J, et al. (2014) Initial effects of the national PCV7 childhood immunization program on adult invasive pneumococcal disease in Israel. PloS One 9: e88406. doi:10.1371/journal.pone.0088406.
17. Steens A, Bergsaker MAR, Aaberge IS, Rønning K, Vestrheim DF (2013) Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine 31: 6232-6238. doi:10.1016/j.vaccine.2013.10.032.
18. Bonten M, Bolkenbaas M, Huijts S, Webber C, Gault S, et al. (2014) Community acquired pneumonia immunisation trial in adults (CAPITA). Pneumonia 3: 95.
19. Horácio AN, Diamantino-Miranda J, Aguiar SI, Ramirez M, Melo-Cristino J, et al. (2013) The majority of adult pneumococcal invasive infections in Portugal are still potentially vaccine preventable in spite of significant declines of serotypes 1 and 5. PLoS ONE 8: e73704. doi:10.1371/journal.pone.0073704.
20. Clinical and Laboratory Standards Institute (2007) Performance standards for antimicrobial susceptibility testing - seventeenth informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
21. Clinical and Laboratory Standards Institute (2013) Performance standards for antimicrobial susceptibility testing - twenty-third informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
22. Melo-Cristino J, Ramirez M, Serrano N, Hänscheid T, The Portuguese Surveillance Group for the Study of Respiratory Pathogens (2003) Macrolide resistance in Streptococcus pneumoniae isolated from patients with community-acquired lower respiratory tract infections in Portugal: results of a 3-year (1999-2001) multicenter surveillance study. Microb Drug Resist 9: 73-80. (Pubitemid 36403060)
23. Carriço JA, Silva-Costa C, Melo-Cristino J, Pinto FR, de Lencastre H, et al. (2006) Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. J Clin Microbiol 44: 2524-2532. (Pubitemid 44092422)
24. Severiano A, Pinto FR, Ramirez M, Carriço JA (2011) Adjusted Wallace coefficient as a measure of congruence between typing methods. J Clin Microbiol 49: 3997-4000. doi:10.1128/JCM.00624-11.
25. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate - a practical and powerful approch to multiple testing. J R Stat Soc Ser B Stat Methodol 57: 289-300.
26. Domenech A, Ardanuy C, Calatayud L, Santos S, Tubau F, et al. (2011) Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease. J Antimicrob Chemother 66: 487-493. doi:10.1093/jac/dkq480.
27. Huijts SM, Pride MW, Vos JMI, Jansen KU, Webber C, et al. (2013) Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia. Eur Respir J 42: 1283-1290. doi:10.1183/09031936.00137412.
28. Aguiar SI, Brito M, Horácio AN, Lopes J, Ramirez M, et al. (2014) Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012. Euro Surveill 19: pii: 20750.
29. Smith AM, Adler FR, Ribeiro RM, Gutenkunst RN, McAuley JL, et al. (2013) Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae. PLoS Pathog 9: e1003238. doi:10.1371/journal.ppat.1003238.
30. 14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J Clin Microbiol 48: 101-108. doi:10.1128/JCM.00665-09.
31. Almeida ST, Nunes S, Santos Paulo AC, Valadares I, Martins S, et al. (2014) Low prevalence of pneumococcal carriage and high serotype and genotype diversity among adults over 60 years of age living in Portugal. PloS One 9: e90974. doi:10.1371/journal.pone.0090974.